PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Interpace Biosciences Inc () from 1998 to Jun 19 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Interpace Biosciences stock (IDXG) PE ratio as of Jun 19 2021 is 0. More Details

Interpace Biosciences PE Ratio (TTM) Chart

EMBED

Interpace Biosciences PE Ratio (TTM) Historical Data

Total 1257
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Interpace Biosciences PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-06-190.0 2021-04-190.0
2021-06-180.0 2021-04-160.0
2021-06-170.0 2021-04-150.0
2021-06-160.0 2021-04-140.0
2021-06-150.0 2021-04-130.0
2021-06-140.0 2021-04-120.0
2021-06-110.0 2021-04-090.0
2021-06-100.0 2021-04-080.0
2021-06-090.0 2021-04-070.0
2021-06-080.0 2021-04-060.0
2021-06-070.0 2021-04-050.0
2021-06-040.0 2021-04-020.0
2021-06-030.0 2021-04-010.0
2021-06-020.0 2021-03-310.0
2021-06-010.0 2021-03-300.0
2021-05-310.0 2021-03-290.0
2021-05-280.0 2021-03-260.0
2021-05-270.0 2021-03-250.0
2021-05-260.0 2021-03-240.0
2021-05-250.0 2021-03-230.0
2021-05-240.0 2021-03-220.0
2021-05-210.0 2021-03-190.0
2021-05-200.0 2021-03-180.0
2021-05-190.0 2021-03-170.0
2021-05-180.0 2021-03-160.0
2021-05-170.0 2021-03-150.0
2021-05-140.0 2021-03-120.0
2021-05-130.0 2021-03-110.0
2021-05-120.0 2021-03-100.0
2021-05-110.0 2021-03-090.0
2021-05-100.0 2021-03-080.0
2021-05-070.0 2021-03-050.0
2021-05-060.0 2021-03-040.0
2021-05-050.0 2021-03-030.0
2021-05-040.0 2021-03-020.0
2021-05-030.0 2021-03-010.0
2021-04-300.0 2021-02-260.0
2021-04-290.0 2021-02-250.0
2021-04-280.0 2021-02-240.0
2021-04-270.0 2021-02-230.0
2021-04-260.0 2021-02-220.0
2021-04-230.0 2021-02-190.0
2021-04-220.0 2021-02-180.0
2021-04-210.0 2021-02-170.0
2021-04-200.0 2021-02-160.0

Interpace Biosciences PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Interpace Biosciences Inc logo

Business Description

Industry
Healthcare » Medical Diagnostics & Research NAICS : 541380 NAICS : 8099
Traded in other countries
Address
300 Interpace Parkway, Morris Corporate Center 1, Building C, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc is engaged in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It operates under one segment which is the business of developing and selling diagnostic clinical and pharma services.